EA201100020A1 - Композиция для местного применения для лечения актинического кератоза - Google Patents

Композиция для местного применения для лечения актинического кератоза

Info

Publication number
EA201100020A1
EA201100020A1 EA201100020A EA201100020A EA201100020A1 EA 201100020 A1 EA201100020 A1 EA 201100020A1 EA 201100020 A EA201100020 A EA 201100020A EA 201100020 A EA201100020 A EA 201100020A EA 201100020 A1 EA201100020 A1 EA 201100020A1
Authority
EA
Eurasian Patent Office
Prior art keywords
actinic keratosis
treatment
composition
local application
active agent
Prior art date
Application number
EA201100020A
Other languages
English (en)
Other versions
EA019533B1 (ru
Inventor
Манфред Мельцер
Кармен Маттис
Клаус Тройдлер
Кристоф Виллерс
Хеннинг Малльвитц
Original Assignee
Альмиралль Хермаль Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40039993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201100020(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Альмиралль Хермаль Гмбх filed Critical Альмиралль Хермаль Гмбх
Publication of EA201100020A1 publication Critical patent/EA201100020A1/ru
Publication of EA019533B1 publication Critical patent/EA019533B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к гелевой композиции для местного применения, содержащей (а) активный агент для лечения актинического кератоза, (б) кератолитически активный агент, (в) гелеобразователь и (г) органический растворитель, для применения для лечения актинического кератоза.
EA201100020A 2008-07-07 2009-06-29 Композиция для местного применения для лечения актинического кератоза EA019533B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08012237A EP2143421A1 (en) 2008-07-07 2008-07-07 Topical composition for the treatment of actinic keratosis
PCT/EP2009/004682 WO2010003568A1 (en) 2008-07-07 2009-06-29 Topical composition for the treatment of actinic keratosis

Publications (2)

Publication Number Publication Date
EA201100020A1 true EA201100020A1 (ru) 2011-06-30
EA019533B1 EA019533B1 (ru) 2014-04-30

Family

ID=40039993

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201100020A EA019533B1 (ru) 2008-07-07 2009-06-29 Композиция для местного применения для лечения актинического кератоза

Country Status (32)

Country Link
US (1) US8569320B2 (ru)
EP (2) EP2143421A1 (ru)
JP (2) JP5654987B2 (ru)
KR (1) KR101689898B1 (ru)
CN (2) CN104825384A (ru)
AR (1) AR072685A1 (ru)
AU (1) AU2009267471B2 (ru)
BR (1) BRPI0915439B8 (ru)
CA (1) CA2729974A1 (ru)
CL (1) CL2010001642A1 (ru)
CO (1) CO6351710A2 (ru)
CY (1) CY1116111T1 (ru)
DK (1) DK2315581T3 (ru)
EA (1) EA019533B1 (ru)
EC (1) ECSP11010762A (ru)
ES (1) ES2532948T3 (ru)
HK (1) HK1154793A1 (ru)
HR (1) HRP20150222T1 (ru)
IL (1) IL210134A (ru)
ME (1) ME02147B (ru)
MX (1) MX2011000054A (ru)
MY (1) MY158428A (ru)
NZ (1) NZ590288A (ru)
PE (1) PE20110330A1 (ru)
PL (1) PL2315581T3 (ru)
PT (1) PT2315581E (ru)
RS (1) RS53887B1 (ru)
SI (1) SI2315581T1 (ru)
TW (1) TWI433692B (ru)
UA (1) UA101044C2 (ru)
WO (1) WO2010003568A1 (ru)
ZA (1) ZA201100653B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012004144A (es) * 2009-10-08 2012-05-08 Msd Consumer Care Inc Composicion de bajo contenido de eter y aparato de administracion.
JP5950528B2 (ja) * 2011-09-30 2016-07-13 小林製薬株式会社 皮膜形成性外用製剤
WO2013088376A1 (en) * 2011-12-12 2013-06-20 Leo Laboratories Limited Gel compositions
NZ606177A (en) * 2012-01-30 2014-03-28 Dolorgiet Gmbh & Co Kg Compositions for the treatment of actinic keratosis
GB201222405D0 (en) * 2012-12-12 2013-01-23 Leo Lab Ltd Gel compositions
RU2017106013A (ru) 2014-07-31 2018-08-28 Сан Фармасьютикал Индастриз Лимитед Фармацевтическая композиция изотретиноина для перорального приема
ES2970434T3 (es) 2014-09-12 2024-05-28 Union Therapeutics As Uso antibacteriano de salicilanilidas halogenadas
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
CA2986295C (en) 2015-07-10 2023-01-03 Infectopharm Arzneimittel Und Consilium Gmbh Use of potassium hydroxide in the treatment of actinic keratosis
GB201604484D0 (en) * 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
IL269182B2 (en) 2017-03-10 2023-11-01 Athenex Inc Methods for the treatment and/or prevention of actinic radiation
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
US20220175769A1 (en) * 2020-12-08 2022-06-09 Ankh Life Sciences Limited Method of treatment of actinic keratoses

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802005A (en) 1957-08-06 S-eluorourace
US4234599A (en) * 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5167649A (en) * 1988-08-22 1992-12-01 Zook Gerald P Drug delivery system for the removal of dermal lesions
US5093360A (en) * 1989-04-07 1992-03-03 Yu Ruey J Retinal, derivatives and their therapeutic use
GB9023701D0 (en) * 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
JP3117502B2 (ja) * 1991-08-27 2000-12-18 株式会社資生堂 皮膚外用剤
US5627187A (en) 1995-04-12 1997-05-06 Katz; Bruce E. 5-FU for treating actinic kerotoses
EP1210937A3 (en) * 1996-06-20 2003-02-05 Lavipharm S.A. Device for topical treatment of acne and its method of manufacture
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US5955097A (en) * 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
US6462071B1 (en) * 2000-03-02 2002-10-08 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
JP2007503428A (ja) * 2003-08-25 2007-02-22 フォーミックス エルティーディー． 浸透性医薬発泡剤
US20050137164A1 (en) * 2003-09-22 2005-06-23 Moshe Arkin Diclofenac compositions for the treatment of skin disorders
CA2570599C (en) * 2004-06-24 2012-03-27 Idexx Laboratories, Inc. Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US20070053984A1 (en) 2005-03-03 2007-03-08 Monique Spann-Wade Topical gels compositions
RS50693B (sr) * 2005-06-14 2010-06-30 Uni-Pharma Kleon Tsetis Pharmaceutical Stabilni farmaceutski gel diklofenak natrijuma
US7851431B2 (en) * 2005-07-27 2010-12-14 Prescription Dispensing Laboratories Treatment of actinic keratoses with calcium channel blockers
US20070264317A1 (en) * 2006-05-15 2007-11-15 Perrigo Israel Pharmaceuticals Ltd. Imiquimod cream formulation
WO2008047857A1 (fr) * 2006-10-18 2008-04-24 Fujifilm Corporation Procédé de production d'une composition comprenant un composé difficilement soluble dans l'eau incorporé dans une matrice hydrophile et préparation pour une utilisation externe comprenant un agent ou médicament anticancéreux ayant un coefficient de partage octanol/eau (log p) de -3,0 ou plus mais pas plus de 3,0, incorporé

Also Published As

Publication number Publication date
MY158428A (en) 2016-10-14
EA019533B1 (ru) 2014-04-30
AU2009267471B2 (en) 2014-06-05
WO2010003568A8 (en) 2011-02-03
ZA201100653B (en) 2011-10-26
CN102088957A (zh) 2011-06-08
HRP20150222T1 (hr) 2015-05-22
JP2015038129A (ja) 2015-02-26
CY1116111T1 (el) 2017-02-08
TWI433692B (zh) 2014-04-11
PT2315581E (pt) 2015-04-02
WO2010003568A1 (en) 2010-01-14
TW201006507A (en) 2010-02-16
EP2315581A1 (en) 2011-05-04
IL210134A0 (en) 2011-02-28
CO6351710A2 (es) 2011-12-20
KR20110027838A (ko) 2011-03-16
JP5654987B2 (ja) 2015-01-14
JP2011526934A (ja) 2011-10-20
PE20110330A1 (es) 2011-06-11
KR101689898B1 (ko) 2016-12-26
UA101044C2 (ru) 2013-02-25
HK1154793A1 (en) 2012-05-04
AU2009267471A1 (en) 2010-01-14
EP2315581B1 (en) 2014-12-17
BRPI0915439B1 (pt) 2019-10-08
CN104825384A (zh) 2015-08-12
ECSP11010762A (es) 2012-03-30
IL210134A (en) 2015-06-30
ME02147B (me) 2015-10-20
US8569320B2 (en) 2013-10-29
NZ590288A (en) 2012-08-31
BRPI0915439B8 (pt) 2021-05-25
PL2315581T3 (pl) 2015-06-30
RS53887B1 (en) 2015-08-31
US20110301130A1 (en) 2011-12-08
ES2532948T3 (es) 2015-04-06
BRPI0915439A2 (pt) 2015-11-10
DK2315581T3 (en) 2015-03-23
CL2010001642A1 (es) 2011-04-08
AR072685A1 (es) 2010-09-15
SI2315581T1 (sl) 2015-05-29
EP2143421A1 (en) 2010-01-13
MX2011000054A (es) 2011-11-04
CA2729974A1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
EA201100020A1 (ru) Композиция для местного применения для лечения актинического кератоза
EA201391030A1 (ru) Композиции моноциклина для местного применения и способы их применения
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
EA201791850A1 (ru) Борсодержащие малые молекулы
EA201070544A1 (ru) Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
ATE449617T1 (de) Hydrogel für wundbehandlung
EA201070247A1 (ru) Ингибиторы протеасом
EA201100037A1 (ru) Органические соединения
EA200802364A1 (ru) Композиция для ухода за кожей и ее применение
MA32562B1 (fr) Composes organiques pour la cicatrisation de lesion
EA200700965A1 (ru) Трегалоза и/или изомальтулоза в качестве носителя для сухой ароматической композиции
BR112013005116A2 (pt) moduladores e métodos de uso
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
EA200901212A1 (ru) 3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеваний
EA201170356A1 (ru) Полиморфные и аморфные формы лакозамида и аморфные композиции
EA201070074A1 (ru) Разлагаемые гели для применения для разобщения зон
CL2009000727A1 (es) Compuestos derivados de n-hidroxi-3-fenilprop-2-enemida y n-hidroxi-3-fenilpropanamida sustituidos; inhibidores de la enzima desacetilasa; su composicion farmaceutica; utiles en el tratamiento del cancer, tumores, psoriasis, alzheimer, entre otras.
EA201001288A1 (ru) Лечение гипертонии 25-гидроксивитамином d3
EA201070009A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
UA107183C2 (uk) Феніламіно-ізонікотинамідні сполуки, їх застосування, фармацевтична композиція, що їх містить, та спосіб лікування гіперпроліферативних захворювань
CL2011000341A1 (es) Compuestos derivados de pirrolidinona sustituida, moduladores de la actividad de ar para la inhibicion de ntd; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de cancer, acne, hirsutismo, entre otras.
EA201170821A1 (ru) Энзастаурин для лечения рака
EA200802229A1 (ru) Фармацевтическая композиция для лечения ожогов (варианты) и способ ее получения (варианты)
EA200870058A1 (ru) Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран
EA200702136A1 (ru) Композиции станнсопорфина и их применение